Plain-English translation of NCT07614984 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new medication called , which is designed to lower levels of lipoprotein(a) — a type of cholesterol that can increase heart disease risk. Researchers want to see if this medication works better when combined with another medication called decanoate, or if it works well on its own. The trial will compare these treatments to placebo to understand which approach is most effective and safe.
Many people have high lipoprotein(a) levels that don't respond well to standard cholesterol medications like statins. This trial exists to find new treatment options for these patients who are at higher risk of heart disease despite being on current medications.
You likely qualify if…
You likely don't qualify if…
You would take a pill by mouth once daily for about 12 weeks. Depending on which group you're randomly assigned to, you might receive the new medication, another medication, both together, or placebo (a pill with no active ingredient). Throughout the study, researchers will check your cholesterol levels with blood tests and monitor you for any side effects to make sure the treatment is safe and working as expected.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
United States